Introduction

Graphic Description – Medicolegal Death Investigation Frequently Used Data Elements for Toxicology and Seized Drugs

Graphic Description – Medicolegal Death Investigation Frequently Used Data Elements for Toxicology and Seized Drugs

Date

February 2024

Overview

The National Institute of Justice (NIJ)—in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)—convened a virtual Medicolegal Death Investigation Data Exchange Working Group (MDI-Data-WG) beginning in September 2020. This working group was formed to: 

  • Document the types of data that are commonly exchanged with public health and public safety partners and determine collective usage points for medicolegal death investigations (MDIs); 
  • Provide recommendations on how to improve the naming process for emerging drugs; 
  • Guide the drug mapping/classification process; and 
  • Recommend needed enhancements to the operation of exchanging forensic data with other organizations. 

This graphic shows the list of data elements that should be considered and reported with toxicology and seized drug (chemistry) cases. This graphic also links these frequently used elements to sections within the report and to overarching categories of death investigation. Items represented as small, closed, and colored circles (e.g., Lab Name), located under each half circle (e.g., Lab and Case Information) are elements that are linked to each other. This graphic can be downloaded and used in training to ensure all are understood and considered for inclusion on reports. Additionally, the graphic can be used to develop checklist for toxicologists and chemists, develop programming characteristics for data developers to code laboratory information, or assist with standardization and consistency among data exchange as part of other resources.



Funding for this Forensic Technology Center of Excellence report was provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice (15PNIJ-21-GK-02192-MUMU). This work was also supported by the Centers for Disease Control and Prevention (Contract Number HHSM500201200008I, Task Order Number 200-2016-F-91567).

The opinions, findings, and conclusions or recommendations expressed in this report are those of the author(s) and do not necessarily reflect those of the U.S. Department of Justice or the Centers for Disease Control and Prevention.

Contact us at ForensicCOE@rti.org with any questions and subscribe to our newsletter for notifications.


Related Content

MDI Myth: We Don’t Need to Worry About Diversity in Medicolegal Death Investigation

← Back to Webinar Series Page Thursday, October 3, 2024 | 1:00 PM – 2:00 PM EasternDuration: 1 hour Overview An organization with a strong Diversity, Equity, and Inclusion (DEI) based philosophy recognizes the diverse voices of the community they…

2024 MDI MythBusters Webinar Series

Overview Following the conceptualization of the popular MythBusters television series (Discovery Channel 2003-2016), this webinar series explores evidence-based methods, operational decision making, and case study findings to prove or disprove common beliefs about medicolegal death investigation. It is widely accepted…